Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population

Coronary Artery Disease

Volumn 24, Issue 4, 2013, Pages 259-265

  Xu, Xin ^a   Wang, Lihan ^a   Xu, Changfu ^b   Zhang, Peng ^c   Yong, Fendi ^d   Liu, Haibo ^e   Wang, Jianan ^a   Shi, Yuping ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d Jiaxing First Hospital   (China)

^e Yinzhou People's Hospital   (China)

Author keywords

Acute coronary syndrome; Angiographic coronary artery disease; Chinese Han population; MMP1 519 A G; MMP3 1171 5A 6A; MMP9 1562 C T; Polymorphism

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CHROMOSOME 11Q; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE CORONARY SYNDROME; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84877069808     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32835ea3af     Document Type: Article

References (38)

1. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92:657-671.
2. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94:2493-2503.
3. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77:863-868.
4. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90: 251-262.
5. Kuzuya M, Iguchi A. Role of matrix metalloproteinases in vascular remodeling. J Atheroscler Thromb 2003; 10:275-282.
6. Newby AC. Dual role of matrix metalloproteinases [matrixins] in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005; 85:1-31.
7. Back M, Ketelhuth DF, Agewall S. Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis 2010; 52:410-428.
8. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T,Welgus HG, Alpers CE, et al. Interstitial collagenase [MMP-1] expression in human carotid atherosclerosis. Circulation 1995; 92:1393-1398.
9. Jurajda M, Muzik J, Izakovicova Holla L, Vacha J. A newly identified single nucleotide polymorphism in the promoter of the matrix metalloproteinase-1 gene. Mol Cell Probes 2002; 16:63-66.
10. Pearce E, Tregouet DA, Samnegard A, Morgan AR, Cox C, Hamsten A, et al. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 2005; 97:1070-1076.
11. Roman-Garcia P, Coto E, Reguero JR, Cannata-Andia JB, Lozano I, Avanzas P, et al. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population. Coron Artery Dis 2009; 20:383-386.
12. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5:2145-2154.
13. Murphy G, Ward R, Gavrilovic J, Atkinson S. Physiological mechanisms for metalloproteinase activation. Matrix Suppl 1992; 1:224-230.
14. Ye S,Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 1995; 73:209-215.
15. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996; 271:13055-13060.
16. Quinones S, Saus J, Otani Y, Harris ED Jr, Kurkinen M. Transcriptional regulation of human stromelysin. J Biol Chem 1989; 264:8339-8344.
17. Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 1997; 96: 3555-3560.
18. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 1999; 105:418-423.
19. Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 2005; 26:481-486.
20. Tang LJ, Chen XF, Zhu M, Jiang JJ, Lu XB, Du YX, et al. Matrix metalloproteinase-1,-3, and-9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population. Clin Biochem 2007; 40:1427-1430.
21. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition- ligationcombination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009; 19:519-523.
22. Nojiri T, Morita H, Imai Y, Maemura K, Ohno M, Ogasawara K, et al. Genetic variations of matrix metalloproteinase-1 and-3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol 2003; 92 (2-3):181-186.
23. Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS. Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron Artery Dis 2010; 21:330-335.
24. Henney AM,Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991; 88: 8154-8158.
25. Borghaei RC, Sullivan C, Mochan E. Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 [MMP-3]. J Biol Chem 1999; 274:2126-2131.
26. Morgan AR, Zhang B, Tapper W, Collins A, Ye S. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med (Berl) 2003; 81:321-326.
27. Zhang B, Ye S, Herrmann SM, Eriksson P, De Maat M, Evans A, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999; 99: 1788-1794.
28. Pollanen PJ, Karhunen PJ, Mikkelsson J, Laippala P, Perola M, Penttila A, et al. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study. Arterioscler Thromb Vasc Biol 2001; 21:1446-1450.
29. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 2004; 24:1479-1484.
30. Zempo N, Kenagy RD, Au YP, Bendeck M, Clowes MM, Reidy MA, et al. Matrix metalloproteinases of vascular wall cells are increased in ballooninjured rat carotid artery. J Vasc Surg 1994; 20:209-217.
31. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 1999; 85:1179-1185.
32. Johnson C, Galis ZS. Matrix metalloproteinase-2 and-9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol 2004; 24:54-60.
33. Li M, Shi J, Fu L, Wang H, Zhou B, Wu X. Genetic polymorphism of MMP family and coronary disease susceptibility: a meta-analysis. Gene 2012; 495:36-41.
34. Lemaitre V, O'Byrne TK, Borczuk AC, Okada Y, Tall AR, D'Armiento J. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest 2001; 107:1227-1234.
35. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004; 75:353-362.
36. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29:233-237.
37. Abd-Allah SH, Shalaby SM, Pasha HF, El-Shal AS, Abou El-Saoud AM. Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis. Genet Test Mol Biomarkers 2012; 16:15-20.
38. Bradbury PA, Zhai R, Hopkins J, Kulke MH, Heist RS, Singh S, et al. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. Carcinogenesis 2009; 30:793-798.